                               SEQUENCE LISTING

<110> THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
      THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 
 
<120> DOMINANT NEGATIVE CEBPB AND CEBPD PROTEINS AND METHODS OF USE FOR
      DECREASING VIABILITY OF NEOPLASTIC CELLS

<130> 070050.6238

<140> PCT/US2019/045518
<141> 2019-08-07

<150> 62/716,123
<151> 2018-08-08

<160> 63    

<170> PatentIn version 3.5

<210> 1
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 1
Leu Glu Thr Gln His Lys Val Leu Glu Leu Thr Ala Glu Asn Glu Arg 
1               5                   10                  15      


Leu Gln Lys Lys Val Glu Gln Leu Ser Arg Glu Leu Ser Thr Leu Arg 
            20                  25                  30          


Asn Leu Phe Lys Gln Leu 
        35              


<210> 2
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 2
Leu Val Glu Leu Ser Ala Glu Asn Glu Lys Leu His Gln Arg Val Glu 
1               5                   10                  15      


Gln Leu Thr Arg Asp Leu Ala Gly Leu Arg Gln Phe Phe Lys 
            20                  25                  30  


<210> 3
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 3
Lys Lys Thr Val Asp Lys His Ser Asp Glu Tyr Lys Ile Arg Arg Glu 
1               5                   10                  15      


Arg Asn Asn Ile Ala Val Arg Lys Ser Arg Asp Lys Ala Lys Met Arg 
            20                  25                  30          


Asn 
    


<210> 4
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Leu Glu Gln Arg Ala Glu Glu Leu Ala Arg Glu Asn Glu Glu Leu Glu 
1               5                   10                  15      


Lys Glu Ala Glu Glu Leu Glu Gln Glu Asn Ala Glu 
            20                  25              


<210> 5
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Leu Ala Arg Glu Asn Glu Glu Leu Glu Lys Glu Ala Glu Glu Leu Glu 
1               5                   10                  15      


Gln Glu Asn Ala Glu 
            20      


<210> 6
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Leu Glu Lys Glu Ala Glu Glu Leu Glu Gln Glu Asn Ala Glu 
1               5                   10                  


<210> 7
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Leu Glu Gln Glu Asn Ala Glu 
1               5           


<210> 8
<211> 128
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (125)..(125)
<223> Ala or Ser

<220>
<221> MOD_RES
<222> (128)..(128)
<223> Cys or Met

<400> 8
Met Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Glu Gln Lys Leu Ile 
1               5                   10                  15      


Ser Glu Glu Asp Leu Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Ala 
            20                  25                  30          


Arg Ala Gly Ser Met Ala Ser Met Thr Gly Gly Gln Gln Met Gly Arg 
        35                  40                  45              


Asp Pro Asp Leu Glu Gln Arg Ala Glu Glu Leu Ala Arg Glu Asn Glu 
    50                  55                  60                  


Glu Leu Glu Lys Glu Ala Glu Glu Leu Glu Gln Glu Asn Ala Glu Leu 
65                  70                  75                  80  


Glu Thr Gln His Lys Val Leu Glu Leu Thr Ala Glu Asn Glu Arg Leu 
                85                  90                  95      


Gln Lys Lys Val Glu Gln Leu Ser Arg Glu Leu Ser Thr Leu Arg Asn 
            100                 105                 110         


Leu Phe Lys Gln Leu Pro Glu Pro Leu Leu Ala Ser Xaa Gly His Xaa 
        115                 120                 125             


<210> 9
<211> 117
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 9
Met Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Glu Gln Lys Leu Ile 
1               5                   10                  15      


Ser Glu Glu Asp Leu Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Ala 
            20                  25                  30          


Arg Ala Gly Ser Met Ala Ser Met Thr Gly Gly Gln Gln Met Gly Arg 
        35                  40                  45              


Asp Pro Asp Leu Glu Gln Arg Ala Glu Glu Leu Ala Arg Glu Asn Glu 
    50                  55                  60                  


Glu Leu Glu Lys Glu Ala Glu Glu Leu Glu Gln Glu Asn Ala Glu Leu 
65                  70                  75                  80  


Glu Thr Gln His Lys Val Leu Glu Leu Thr Ala Glu Asn Glu Arg Leu 
                85                  90                  95      


Gln Lys Lys Val Glu Gln Leu Ser Arg Glu Leu Ser Thr Leu Arg Asn 
            100                 105                 110         


Leu Phe Lys Gln Leu 
        115         


<210> 10
<211> 89
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 10
Met Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Glu Gln Lys Leu Ile 
1               5                   10                  15      


Ser Glu Glu Asp Leu Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Ala 
            20                  25                  30          


Arg Ala Gly Ser Met Ala Ser Met Thr Gly Gly Gln Gln Met Gly Arg 
        35                  40                  45              


Asp Pro Asp Leu Glu Thr Gln His Lys Val Leu Glu Leu Thr Ala Glu 
    50                  55                  60                  


Asn Glu Arg Leu Gln Lys Lys Val Glu Gln Leu Ser Arg Glu Leu Ser 
65                  70                  75                  80  


Thr Leu Arg Asn Leu Phe Lys Gln Leu 
                85                  


<210> 11
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu 
1               5                   10  


<210> 12
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 12
Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Glu Gln Lys Leu Ile Ser 
1               5                   10                  15      


Glu Glu Asp Leu Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu 
            20                  25                  30  


<210> 13
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Gly Leu Asn Asp Ile Phe Glu Ala Gln Lys Ile Glu Trp His Glu 
1               5                   10                  15  


<210> 14
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Lys Arg Arg Trp Lys Lys Asn Phe Ile Ala Val Ser Ala Ala Asn Arg 
1               5                   10                  15      


Phe Lys Lys Ile Ser Ser Ser Gly Ala Leu 
            20                  25      


<210> 15
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Glu Glu Glu Glu Glu Glu 
1               5       


<210> 16
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Gly Ala Pro Val Pro Tyr Pro Asp Pro Leu Glu Pro Arg 
1               5                   10              


<210> 17
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Asp Tyr Lys Asp Asp Asp Asp Lys 
1               5               


<210> 18
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Tyr Pro Tyr Asp Val Pro Asp Tyr Ala 
1               5                   


<210> 19
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
His His His His His His 
1               5       


<210> 20
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu 
1               5                   10  


<210> 21
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 21
Thr Lys Glu Asn Pro Arg Ser Asn Gln Glu Glu Ser Tyr Asp Asp Asn 
1               5                   10                  15      


Glu Ser 
        


<210> 22
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 22
Lys Glu Thr Ala Ala Ala Lys Phe Glu Arg Gln His Met Asp Ser 
1               5                   10                  15  


<210> 23
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 23
Met Asp Glu Lys Thr Thr Gly Trp Arg Gly Gly His Val Val Glu Gly 
1               5                   10                  15      


Leu Ala Gly Glu Leu Glu Gln Leu Arg Ala Arg Leu Glu His His Pro 
            20                  25                  30          


Gln Gly Gln Arg Glu Pro 
        35              


<210> 24
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 24
Ser Leu Ala Glu Leu Leu Asn Ala Gly Leu Gly Gly Ser 
1               5                   10              


<210> 25
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 25
Thr Gln Asp Pro Ser Arg Val Gly 
1               5               


<210> 26
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 26
Trp Ser His Pro Gln Phe Glu Lys 
1               5               


<210> 27
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 27
Cys Cys Pro Gly Cys Cys 
1               5       


<210> 28
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 28
Gly Lys Pro Ile Pro Asn Pro Leu Leu Gly Leu Asp Ser Thr 
1               5                   10                  


<210> 29
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 29
Tyr Thr Asp Ile Glu Met Asn Arg Leu Gly Lys 
1               5                   10      


<210> 30
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 30
Asp Leu Tyr Asp Asp Asp Asp Lys 
1               5               


<210> 31
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 31
Thr Asp Lys Asp Met Thr Ile Thr Phe Thr Asn Lys Lys Asp Ala Glu 
1               5                   10                  15      


<210> 32
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 32
Ala His Ile Val Met Val Asp Ala Tyr Lys Pro Thr Lys 
1               5                   10              


<210> 33
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 33
Lys Leu Gly Asp Ile Glu Phe Ile Lys Val Asn Lys 
1               5                   10          


<210> 34
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 34
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210> 35
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 35
Arg Arg Leu Arg Arg Leu Leu Arg Arg Leu Leu Arg Arg Leu Arg Arg 
1               5                   10                  15      


<210> 36
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 36
Arg Val Gly Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10          


<210> 37
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 37
Gly Trp Thr Leu Asn Ser Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu 
1               5                   10                  15      


Lys Ala Leu Ala Ala Leu Ala Lys Lys Ile Leu 
            20                  25          


<210> 38
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 38
Pro Val Ile Arg Val Trp Phe Gln Asn Lys Arg Cys Lys Asp Lys Lys 
1               5                   10                  15      


<210> 39
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 39
Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210> 40
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 40
Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln 
1               5                   10              


<210> 41
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 41
Leu Leu Ile Ile Leu Arg Arg Arg Ile Arg Lys Gln Ala His Ala His 
1               5                   10                  15      


<210> 42
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 42
Gly Ala Leu Phe Leu Gly Trp Leu Gly Ala Ala Gly Ser Thr Met Gly 
1               5                   10                  15      


Ala Trp Ser Gln Pro Lys Lys Lys Arg Lys Val 
            20                  25          


<210> 43
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 43
Lys Leu Ala Leu Lys Leu Ala Leu Lys Ala Leu Lys Ala Ala Leu Lys 
1               5                   10                  15      


Leu Ala 
        


<210> 44
<211> 118
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (115)..(115)
<223> Ala or Ser

<220>
<221> MOD_RES
<222> (118)..(118)
<223> Cys or Met

<400> 44
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Met Ala Ser Met Thr Gly 
            20                  25                  30          


Gly Gln Gln Met Gly Arg Asp Pro Asp Leu Glu Gln Arg Ala Glu Glu 
        35                  40                  45              


Leu Ala Arg Glu Asn Glu Glu Leu Glu Lys Glu Ala Glu Glu Leu Glu 
    50                  55                  60                  


Gln Glu Asn Ala Glu Leu Glu Thr Gln His Lys Val Leu Glu Leu Thr 
65                  70                  75                  80  


Ala Glu Asn Glu Arg Leu Gln Lys Lys Val Glu Gln Leu Ser Arg Glu 
                85                  90                  95      


Leu Ser Thr Leu Arg Asn Leu Phe Lys Gln Leu Pro Glu Pro Leu Leu 
            100                 105                 110         


Ala Ser Xaa Gly His Xaa 
        115             


<210> 45
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 45
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Met Ala Ser Met Thr Gly 
            20                  25                  30          


Gly Gln Gln Met Gly Arg Asp Pro Asp Leu Glu Gln Arg Ala Glu Glu 
        35                  40                  45              


Leu Ala Arg Glu Asn Glu Glu Leu Glu Lys Glu Ala Glu Glu Leu Glu 
    50                  55                  60                  


Gln Glu Asn Ala Glu Leu Glu Thr Gln His Lys Val Leu Glu Leu Thr 
65                  70                  75                  80  


Ala Glu Asn Glu Arg Leu Gln Lys Lys Val Glu Gln Leu Ser Arg Glu 
                85                  90                  95      


Leu Ser Thr Leu Arg Asn Leu Phe Lys Gln Leu 
            100                 105         


<210> 46
<211> 79
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 46
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Met Ala Ser Met Thr Gly 
            20                  25                  30          


Gly Gln Gln Met Gly Arg Asp Pro Asp Leu Glu Thr Gln His Lys Val 
        35                  40                  45              


Leu Glu Leu Thr Ala Glu Asn Glu Arg Leu Gln Lys Lys Val Glu Gln 
    50                  55                  60                  


Leu Ser Arg Glu Leu Ser Thr Leu Arg Asn Leu Phe Lys Gln Leu 
65                  70                  75                  


<210> 47
<211> 82
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 47
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Leu Glu Gln Arg Ala Glu Glu Leu Ala Arg Glu Asn Glu Glu Leu Glu 
            20                  25                  30          


Lys Glu Ala Glu Glu Leu Glu Gln Glu Asn Ala Glu Leu Glu Thr Gln 
        35                  40                  45              


His Lys Val Leu Glu Leu Thr Ala Glu Asn Glu Arg Leu Gln Lys Lys 
    50                  55                  60                  


Val Glu Gln Leu Ser Arg Glu Leu Ser Thr Leu Arg Asn Leu Phe Lys 
65                  70                  75                  80  


Gln Leu 
        


<210> 48
<211> 54
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 48
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Leu Glu Thr Gln His Lys Val Leu Glu Leu Thr Ala Glu Asn Glu Arg 
            20                  25                  30          


Leu Gln Lys Lys Val Glu Gln Leu Ser Arg Glu Leu Ser Thr Leu Arg 
        35                  40                  45              


Asn Leu Phe Lys Gln Leu 
    50                  


<210> 49
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 49
Arg Gln Ile Lys Ile Phe Phe Gln Asn Arg Arg Met Lys Phe Lys Lys 
1               5                   10                  15      


<210> 50
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 50
Arg Gln Ile Lys Ile Trp Phe Arg Lys Trp Lys Lys 
1               5                   10          


<210> 51
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 51
Asp Arg Gly Ser Pro Glu Tyr Arg Gln Arg Arg Glu Arg Asn Asn Ile 
1               5                   10                  15      


Ala Val Arg Lys Ser Arg Asp Lys Ala Lys Arg Arg Asn Gln Glu Met 
            20                  25                  30          


Gln Gln Lys 
        35  


<210> 52
<211> 126
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (125)..(125)
<223> Cys or Met

<400> 52
Met Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Glu Gln Lys Leu Ile 
1               5                   10                  15      


Ser Glu Glu Asp Leu Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Ala 
            20                  25                  30          


Arg Ala Gly Ser Met Ala Ser Met Thr Gly Gly Gln Gln Met Gly Arg 
        35                  40                  45              


Asp Pro Asp Leu Glu Gln Arg Ala Glu Glu Leu Ala Arg Glu Asn Glu 
    50                  55                  60                  


Glu Leu Glu Lys Glu Ala Glu Glu Leu Glu Gln Glu Asn Ala Glu Leu 
65                  70                  75                  80  


Val Glu Leu Ser Ala Glu Asn Glu Lys Leu His Gln Arg Val Glu Gln 
                85                  90                  95      


Leu Thr Arg Asp Leu Ala Gly Leu Arg Gln Phe Phe Lys Gln Leu Pro 
            100                 105                 110         


Ser Pro Pro Phe Leu Pro Ala Ala Gly Thr Ala Asp Xaa Arg 
        115                 120                 125     


<210> 53
<211> 109
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 53
Met Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Glu Gln Lys Leu Ile 
1               5                   10                  15      


Ser Glu Glu Asp Leu Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Ala 
            20                  25                  30          


Arg Ala Gly Ser Met Ala Ser Met Thr Gly Gly Gln Gln Met Gly Arg 
        35                  40                  45              


Asp Pro Asp Leu Glu Gln Arg Ala Glu Glu Leu Ala Arg Glu Asn Glu 
    50                  55                  60                  


Glu Leu Glu Lys Glu Ala Glu Glu Leu Glu Gln Glu Asn Ala Glu Leu 
65                  70                  75                  80  


Val Glu Leu Ser Ala Glu Asn Glu Lys Leu His Gln Arg Val Glu Gln 
                85                  90                  95      


Leu Thr Arg Asp Leu Ala Gly Leu Arg Gln Phe Phe Lys 
            100                 105                 


<210> 54
<211> 81
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 54
Met Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Glu Gln Lys Leu Ile 
1               5                   10                  15      


Ser Glu Glu Asp Leu Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Ala 
            20                  25                  30          


Arg Ala Gly Ser Met Ala Ser Met Thr Gly Gly Gln Gln Met Gly Arg 
        35                  40                  45              


Asp Pro Asp Leu Val Glu Leu Ser Ala Glu Asn Glu Lys Leu His Gln 
    50                  55                  60                  


Arg Val Glu Gln Leu Thr Arg Asp Leu Ala Gly Leu Arg Gln Phe Phe 
65                  70                  75                  80  


Lys 
    


<210> 55
<211> 116
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (115)..(115)
<223> Cys or Met

<400> 55
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Met Ala Ser Met Thr Gly 
            20                  25                  30          


Gly Gln Gln Met Gly Arg Asp Pro Asp Leu Glu Gln Arg Ala Glu Glu 
        35                  40                  45              


Leu Ala Arg Glu Asn Glu Glu Leu Glu Lys Glu Ala Glu Glu Leu Glu 
    50                  55                  60                  


Gln Glu Asn Ala Glu Leu Val Glu Leu Ser Ala Glu Asn Glu Lys Leu 
65                  70                  75                  80  


His Gln Arg Val Glu Gln Leu Thr Arg Asp Leu Ala Gly Leu Arg Gln 
                85                  90                  95      


Phe Phe Lys Gln Leu Pro Ser Pro Pro Phe Leu Pro Ala Ala Gly Thr 
            100                 105                 110         


Ala Asp Xaa Arg 
        115     


<210> 56
<211> 99
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 56
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Met Ala Ser Met Thr Gly 
            20                  25                  30          


Gly Gln Gln Met Gly Arg Asp Pro Asp Leu Glu Gln Arg Ala Glu Glu 
        35                  40                  45              


Leu Ala Arg Glu Asn Glu Glu Leu Glu Lys Glu Ala Glu Glu Leu Glu 
    50                  55                  60                  


Gln Glu Asn Ala Glu Leu Val Glu Leu Ser Ala Glu Asn Glu Lys Leu 
65                  70                  75                  80  


His Gln Arg Val Glu Gln Leu Thr Arg Asp Leu Ala Gly Leu Arg Gln 
                85                  90                  95      


Phe Phe Lys 
            


<210> 57
<211> 71
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 57
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Met Ala Ser Met Thr Gly 
            20                  25                  30          


Gly Gln Gln Met Gly Arg Asp Pro Asp Leu Val Glu Leu Ser Ala Glu 
        35                  40                  45              


Asn Glu Lys Leu His Gln Arg Val Glu Gln Leu Thr Arg Asp Leu Ala 
    50                  55                  60                  


Gly Leu Arg Gln Phe Phe Lys 
65                  70      


<210> 58
<211> 74
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 58
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Leu Glu Gln Arg Ala Glu Glu Leu Ala Arg Glu Asn Glu Glu Leu Glu 
            20                  25                  30          


Lys Glu Ala Glu Glu Leu Glu Gln Glu Asn Ala Glu Leu Val Glu Leu 
        35                  40                  45              


Ser Ala Glu Asn Glu Lys Leu His Gln Arg Val Glu Gln Leu Thr Arg 
    50                  55                  60                  


Asp Leu Ala Gly Leu Arg Gln Phe Phe Lys 
65                  70                  


<210> 59
<211> 46
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 59
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Leu Val Glu Leu Ser Ala Glu Asn Glu Lys Leu His Gln Arg Val Glu 
            20                  25                  30          


Gln Leu Thr Arg Asp Leu Ala Gly Leu Arg Gln Phe Phe Lys 
        35                  40                  45      


<210> 60
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (8)..(8)
<223> Ala or Ser

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Cys or Met

<400> 60
Pro Glu Pro Leu Leu Ala Ser Xaa Gly His Xaa 
1               5                   10      


<210> 61
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 61
Met Ala Ser Met Thr Gly Gly Gln Gln Met Gly 
1               5                   10      


<210> 62
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (16)..(16)
<223> Cys or Met

<400> 62
Gln Leu Pro Ser Pro Pro Phe Leu Pro Ala Ala Gly Thr Ala Asp Xaa 
1               5                   10                  15      


Arg 
    

<210> 63
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (1)..(10)
<223> This sequence may encompass 5-10 residues

<400> 63
His His His His His His His His His His 
1               5                   10  



